ERBB2 and breast carcinoma: The gene signature did not significantly stratify patients in other subtypes of breast cancer (all breast cancers, p = 0.061, Figure 4A; ER+HER2− breast cancers, p = 0.969, Figure 4B; TNBC, p = 0.101, Figure 4D).